This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Palmitoyl ethanolamide-d4 (PEA-d4) is intended for use as an internal standard for the quantification of PEA (Cay-90350) by GC- or LC-MS. PEA is an endogenous fatty N-acyl ethanolamine and a derivative of the endocannabinoid arachidonoyl ethanolamide (AEA, Cay-90050). It selectively activates peroxisome proliferator-activated receptor alpha (PPARalpha, EC50 = 3.1 µM) over PPARbeta/delta and PPARgamma in HeLa cells expressing the human receptors. PEA binds to RBL-2H3 basophil membranes (IC50 = 1 nM), which endogenously express cannabinoid 2 (CB2), but not CB1, receptors, and inhibits antigen-induced serotonin release from RBL-2H3 cells (EC50 = 0.27 µM). It prevents decreases in paw withdrawal latency in a radiant heat hypersensitivity test, an effect that can be reversed by the CB1 receptor antagonist SR141716 (rimonabant, Cay-9000484), PPARgamma antagonist GW 9662 (Cay-70785), and transient receptor potential vanilloid 1 (TRPV1) antagonist capsazepine (Cay-10007518), in a mouse model of neuropathic pain induced by chronic constriction injury of the sciatic nerve. PEA (10 mg/kg) decreases carrageenan-induced paw edema in wild-type, but not Ppara-/-, mice. It inhibits tonic convulsions induced by pentylenetetrazole (PTZ, Cay-18682) in rats when administered at a dose of 40 mg/kg. Formulations containing palmitoyl ethanolamide have been used as dietary supplements.Formal Name: N-(2-hydroxyethyl-1,1',2,2'-d4)-hexadecanamide. CAS Number: 946524-34-1. Synonyms: Palmidrol-d4, Palmityl Ethanolamide-d4, PEA-hydroxyethyl-1,1,2,2-d4. Molecular Formula: C18H33D4NO2. Formula Weight: 303.5. Purity: >99% deuterated forms (d1-d4). Formulation: (Request formulation change), A solution in ethanol. Solubility: DMF: 10 mg/ml, DMSO: 5 mg/ml, Ethanol: 2 mg/ml, Ethanol:PBS (pH 7.2) (1:10): .01 mg/ml. SMILES: OC([2H])([2H])C([2H])([2H])N([H])C(CCCCCCCCCCCCCCC)=O. InChi Code: InChI=1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)19-16-17-20/h20H,2-17H2,1H3,(H,19,21)/i16D2,17D2. InChi Key: HXYVTAGFYLMHSO-RZOBCMOLSA-N.
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the usability of this website, serve for direct advertising or simplify interaction with other websites and social networks, will only be used with your consent.
More information